Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 3, Issue 4, 2007, Pages 258-265

  Zhang, Jing ^a   Chen, Xi Guang ^a   Li, Yan Yan ^a   Liu, Cheng Sheng ^a  

^a OCEAN UNIVERSITY OF CHINA   (China)

Author keywords

Doxorubicin; Drug release; Inhibitory rate; Nanoparticles; Oleoyl chitosan (OCH)

Indexed keywords

DOXORUBICIN; DRUG RELEASE; INHIBITORY RATE; OLEOYL-CHITOSAN (OCH);

BIOASSAY; DRUG PRODUCTS; HYDROPHOBICITY; SELF ASSEMBLY;

NANOPARTICLES;

CHITOSAN DERIVATIVE; DOXORUBICIN; DRUG CARRIER; NANOPARTICLE; OLEOYL CHITOSAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL SUSPENSION; CONTROLLED STUDY; CYTOTOXICITY; EMBRYO; EMBRYO CELL; ENCAPSULATION; FIBROBLAST; HELA CELL; HEMOLYSIS; HUMAN; HUMAN CELL; HYDROPHOBICITY; IN VITRO STUDY; MOUSE; NONHUMAN; PARTICLE SIZE; PH; SUSTAINED DRUG RELEASE; TOXICITY TESTING;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; CHITOSAN; CRYSTALLIZATION; DELAYED-ACTION PREPARATIONS; DIFFUSION; DOXORUBICIN; DRUG CARRIERS; FIBROBLASTS; HUMANS; HYDROPHOBICITY; MATERIALS TESTING; MICE; NANOPARTICLES; NEOPLASMS; PARTICLE SIZE;

EID: 36549084546     PISSN: 15499634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nano.2007.08.002     Document Type: Article

References (29)

1. Kumar M.N.V.R. A review of chitin and chitosan applications. React Funct Polym 46 (2000) 1-27
2. Khor E., and Lim L.Y. Implantable applications of chitin and chitosan. Biomaterials 24 (2003) 2339-2349
3. Kim K., Kwon S., Park J.H., Chung H., Jeong S.Y., Kwon I.C., et al. Physicochemical characterizations of self-assembled nanoparticles of glycol chitosan-deoxycholic acid conjugates. Biomacromolecules 6 (2005) 1154-1158
4. Lee K.Y., Kim J.H., Kwon I.C., and Jeong S.Y. Self-aggregates of deoxycholic acid-modified chitosan as a novel carrier of adriamycin. Colloid Polym Sci 278 (2000) 1216-1219
5. Liu C.G., Desai K.G.H., Chen X.G., and Park H.J. Linolenic acid-modified chitosan for formation of self-assembled nanoparticles. J Agric Food Chem 53 (2005) 437-441
6. Chen X.G., Lee C.M., and Park H.J. O/W emulsification for the self-aggregation and nanoparticle formation of linoleic acid-modified chitosan in the aqueous system. J Agric Food Chem 51 (2003) 3135-3139
7. Yoshioka H., Nonaka K., Fukuda K., and Kazama S. Chitosan-derived polymer-surfactants and their micellar properties. Biosci Biotech Biochem 59 (1995) 1901-1904
8. Menendez J.A., Papadimitropoulou A., Vellon L., Colomer R., and Lupu R. A genomic explanation connecting "Mediterranean diet", olive oil and cancer: oleic acid, the main monounsaturated fatty acid of olive oil, induces formation of inhibitory "PEA3 transcription factor-PEA3 DNA binding site" complexes at the Her-2/neu (erbB-2) oncogene promoter in breast, ovarian and stomach cancer cells. Eur J Cancer 42 (2006) 2425-2432
9. Menéndez J.A., del Mar Barbacid M., Montero S., Sevilla E., Escrich E., Solanas M., et al. Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells. Eur J Cancer 37 (2001) 402-413
10. Gref R., Minamitake Y., Peracchia M.T., Trubetskoy V., Torchilin V., and Langer R. Biodegradable long-circulating polymeric nanospheres. Science 263 (1994) 1600-1603
11. Matsumura Y., and Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46 (1986) 6387-6392
12. Son Y.J., Jang J.S., Cho Y.W., Chung H., Park R.W., Kwon I.C.., et al. Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect. J Control Release 91 (2003) 135-145
13. Kim J.H., Kim Y.S., Kim S.W., Park H., Kim K., Choi K., et al. Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel. J Control Release 111 (2006) 228-234
14. Park J.S., Han T.H., Lee K.Y., Han S.S., Hwang J.J., Moon D.H., et al. N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug release. J Control Release 115 (2006) 37-45
15. Park J.H., Kwon S., Nam J.O., Park R.W., Chung H., Seo S.B., et al. Self-assembled nanoparticles based on glycol chitosan bearing 5β-cholanic acid for RGD peptide delivery. J Control Release 95 (2004) 579-588
16. Park J.H., Kwon S., Lee M., Chung H., Kim J.H., Kim Y.S., et al. Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity. Biomaterials 27 (2006) 119-126
17. Li Y.Y., Chen X.G., Yu L.M., Wang S.X., Sun G.Z., and Zhou H.Y. Aggregation of hydrophobically modified chitosan in solution and at the air-water interface. J Appl Polym Sci 102 (2006) 1968-1973
18. Le-Tien C., Lacroix M., Ispas-Szabo P., and Mateescu M.A. N-acylated chitosan: hydrophobic matrices for controlled drug release. J Control Release 93 (2003) 1-13
19. Jumma M., Furkert F.H., and Müller B.W. A new lipid emulsion formulation with high antimicrobial efficacy using chitosan. Eur J Pharm Biopharm 53 (2002) 115-123
20. Hansen M.B., Nielsen S.E., and Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119 (1989) 203-210
21. Govender T., Stolnik S., Garnett M.C., Illum L., and Davis S. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Release 52 (1999) 171-185
22. Rao S.B., and Sharma C.P. Use of chitosan as a biomaterial: studies on its safety and hemostatic potential. J Biomed Mater Res 34 (1997) 21-28
23. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 (1983) 55-63
24. He P., Davis S.S., and Illum L. In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int J Pharm 166 (1998) 75-88
25. Calvo P., Vila-Jato J.L., and Alonso M.J. Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers. Int J Pharm 153 (1997) 41-50
26. Yuan F., Leunig M., Huang S.K., Berk D.A., Papahadjopoulos D., and Jain R.K. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res 54 (1994) 3352-3356
27. Yuan F., Dellian M., Fukumura D., Leunig M., Berk D.A., Torchilin V.P., et al. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 55 (1995) 3752-3756
28. Yokoyama M., Okano T., Sakurai Y., Ekimoto H., Shibazaki C., Kataoka K., et al. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res 51 (1991) 3229-3236
29. Hashizume H., Baluk P., Morikawa S., McLean J.W., Thurston G., Roberge S., et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 156 (2000) 1363-1380